PPP2R1A and ovarian endometrioid adenocarcinoma: Molecular profiling of human endometrioid ovarian cancers revealed that the most prevalent mutations are similar to those observed in clear-cell ovarian cancer and include PIK3CA (40%), ARID1A (30%), KRAS (30%), PTEN (16%), and PPP2R1A (16%) [32,33].